Reading the tape
NYSE: GRDN
Guardian Pharmacy Services, Inc.
Healthcare · Medical - Distribution
Market Cap
$2.32B
52w High
$41.36
52w Low
$19.17
P/E
47.14
Volume
291.61K
Outstanding Shares
63.34M
Price vs Fundamentals
Why The Stock Is Moving
Fundamentals are supporting the moveModerate confidence
Note: The most recent financial data is over 3 months old. Metrics shown may not reflect the latest reporting period.
1Y Price: 44.08%Revenue (TTM): 17.93%FCF (TTM): 94.05%
What changed
The stock rose 44.08% over the last year. Revenue grew 17.93% over the trailing twelve months. Operating margin moved from -5.12% to 6.14%. Free cash flow grew 94.05% over the trailing twelve months.
What the market seems to be pricing
The stock move broadly lines up with stronger business momentum. The operating data is doing enough work that the move does not need an overvaluation story to explain it.
What would invalidate this read
Operating margin is at 6.14%. Revenue grew 17.93% — this thesis depends on that trajectory holding. If revenue growth, margins, or free cash flow roll over while the stock keeps climbing, more of the move would be coming from multiple expansion than business progress.
Company profile
Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States.
CEOFred Burke
SectorHealthcare
IndustryMedical - Distribution
Employees3,400
IPO dateApr 21, 2016
Valuation
Forward P/E—
EV/EBITDA16.69
Enterprise value$1.86B
Stock splits
No stock splits recorded for this ticker.
Profitability & growth
Revenue growth17.44%
Gross margin19.47%▼2.13%vs FY2024
Operating margin6.14%▲219.83%vs FY2024
ROE23.92%▲139.10%vs FY2024
Analyst consensus
RatingBuy
Target price$38.00▲3.71%
3
Buy
0
Hold
0
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
May 6, 2026
Q2 FY26 · EPS est $0.24 · Revenue est $329.89M
View